In common with its localization in myometrium [31], placental cytotrophoblasts [32], endothelium [33] keratinocytes [34] and prostate cancer cells [35], immunofluorescence for endometrial TREK-1 was observed in the cell membrane, cytoplasm and nuclei. Here, KCNK2 is linked to prostate carcinoma.